BrainStorm Cell Therapeutics
BCLI
#10412
Rank
C$8.27 M
Marketcap
C$0.75
Share price
-3.57%
Change (1 day)
-74.24%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -C$15.27 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$16.15 Million, an increase over its 2023 earnings that were of -C$23.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$15.27 Million-5.43%
2024 -C$16.15 Million-32.39%
2023 -C$23.89 Million-29.18%
2022 -C$33.73 Million-0.74%
2021 -C$33.98 Million-23.12%
2020 -C$44.2 Million36.8%
2019 -C$32.31 Million66.71%
2018 -C$19.38 Million181.66%
2017 -C$6.88 Million-0.6%
2016 -C$6.93 Million-41.31%
2015 -C$11.8 Million-8.22%
2014 -C$12.85 Million89.74%
2013 -C$6.78 Million42.27%
2012 -C$4.76 Million-12.45%
2011 -C$5.44 Million63.04%
2010 -C$3.34 Million35.52%
2009 -C$2.47 Million-48.99%
2008 -C$4.83 Million-44.39%
2007 -C$8.68 Million
2005 -C$4.5 Million-91.44%
2004 -C$52.49 Million94007.62%
2003 -C$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
C$13.73 B-91,248.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-C$1.05 Billion 6,832.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-C$1.1 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.64 B-17,654.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$28.7 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-C$0.36 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA